Outstanding results...........there is no reason why an oncologist would choose mono keytruda or Keytruda+chemo over Ketytruda+Efti .
This combo has all the benefits of Keytruda alone plus an almost 7 times ORR of mono keytruda an an improved rate over Keytruda+ chemo
FDA hopefully will approve this combo and not ask for yet another expanded trial.
- Forums
- ASX - By Stock
- IMM
- Ann: Webcast to discuss data presented at ESMO Plenary Session
IMM
immutep limited
Add to My Watchlist
1.79%
!
27.5¢

Ann: Webcast to discuss data presented at ESMO Plenary Session, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $403.6M |
Open | High | Low | Value | Volume |
28.0¢ | 28.3¢ | 27.0¢ | $334.9K | 1.206M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 572821 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 144039 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 567522 | 0.270 |
20 | 474110 | 0.265 |
12 | 340416 | 0.260 |
18 | 646141 | 0.255 |
17 | 287729 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 150790 | 24 |
0.280 | 715392 | 14 |
0.285 | 509207 | 20 |
0.290 | 469904 | 13 |
0.295 | 154221 | 9 |
Last trade - 11.57am 08/08/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |